Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin 11

V F Quesniaux1

  • 1Preclinical Research, Sandoz Pharma Ltd., Basel, Switzerland.

Leukemia & Lymphoma
|July 1, 1994
PubMed
Summary

Interleukin-11 (IL-11) significantly enhances early hematopoiesis, particularly erythropoiesis, when combined with other growth factors like IL-3 and c-kit ligand. This cytokine plays a crucial role in bone marrow stem cell development and blood cell production.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sanglifehrin A, a novel cyclophilin-binding compound showing immunosuppressive activity with a new mechanism of action.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same author

The novel immunosuppressant FTY720 induces peripheral lymphodepletion of both T- and B-cells in cynomolgus monkeys when given alone, with Cyclosporine Neoral or with RAD.

Transplant immunology·2001
Same author

Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin.

Antimicrobial agents and chemotherapy·1999
Same author

Relative affinity of CHI 621 for T-cell blasts of humans, rhesus, cynomolgus monkeys and dogs.

Transplantation proceedings·1998
Same author

Cymbimicin A and B, two novel cyclophilin-binding structures isolated from actinomycetes.

The Journal of antibiotics·1998
Same author

Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-alpha double-deficient mice infected with Candida albicans.

International immunology·1998

Area of Science:

  • Hematology
  • Cell Biology
  • Cytokine Signaling

Background:

  • Interleukin-11 (IL-11) is a pleiotropic cytokine with diverse biological activities.
  • IL-11 shares some functions with IL-6, including B cell maturation and myeloid differentiation, but notably inhibits adipogenesis.
  • Its distinct role in erythropoiesis differentiates it from IL-6.

Purpose of the Study:

  • To investigate the specific effects of IL-11 on various stages of erythropoiesis.
  • To explore the synergistic effects of IL-11 in combination with other hematopoietic growth factors.
  • To elucidate the role of IL-11 in early hematopoiesis within the bone marrow microenvironment.

Main Methods:

  • In vitro studies using hematopoietic progenitor cell cultures.
  • Assays to evaluate colony-forming unit (CFU) activity for different cell lineages.
  • In vivo administration of recombinant human IL-11 in animal models (mice and primates).

Main Results:

  • IL-11 alone sustains terminal differentiation of late erythroid progenitors (CFU-E).
  • Combined IL-11 with IL-3 profoundly stimulates early multipotent hematopoietic progenitors (pre-CFCmulti) and erythroid progenitors.
  • IL-11 synergizes with the c-kit ligand (KL) to promote multiplication of early progenitors and erythroblast colony formation.
  • In vivo studies showed increased circulating neutrophils and platelets, and enhanced megakaryopoiesis.

Conclusions:

  • IL-11 plays a pivotal role in early hematopoiesis, especially erythropoiesis, through synergistic interactions with stromal factors like KL.
  • IL-11 is a key regulator of hematopoietic stem and progenitor cell proliferation and differentiation.
  • IL-11 demonstrates therapeutic potential for modulating blood cell production in vivo.

Related Experiment Videos